| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424473000 | With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.) | 14 |
| 20080299197 | Triple Combination Release Multi-Layered Tablet - This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet ( | 12-04-2008 |
| 20090304794 | CONTROLLED RELEASE FORMULATIONS OF PRAMIPEXOLE - A controlled release formulation of pramipexole for once-a-day administration to a mammalian subject, which formulation releases pramipexole along a pre-determined release profile, is provided. | 12-10-2009 |
| 20100112055 | MICROPOROUS FILM AND PREPARATION AND USE THEREOF - The present invention is a new type of microporous film. The micoporous film can be applied to use as coating material of controlling drug release. The present invention also relates to a preparation of the microporous film. | 05-06-2010 |
| 20100143472 | OSMOTIC FORM FOR CONTROLLED RELEASE OF ACTIVE PRINCIPLES - The present invention refers to a tablet-shaped osmotic release system providing, in a controlled way, active principles which solubility depends on the pH of the medium, simultaneously providing appropriate solubilization throughout the gastrointestinal tract. The pharmaceutical osmotic release system comprises of a pharmaceutical layer, which contains at least one active principle in a solid solution, a propelling layer, which contains at least one osmopolymer and at least one osmoagent, a semipermeable coating involving both layers, and at least one orifice in the semipermeable coating at the side of the pharmaceutical layer. | 06-10-2010 |
| 20100291208 | CONTROLLED POROUS OSMOTIC PUMP TABLETS OF HIGH PERMEABLE DRUGS AND THE PREPARATION PROCESS THEREOF - The present invention relates to controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof. The controlled porosity osmotic pump tablets do not need to be drilled by laser, but provides controlled porosity for drug release by adding a suitable quantity of pore-forming agents into the semipermeable membrane. In specific embodiments, the present invention relates to controlled porous osmotic pump tablets comprising venlafaxine or metoprolol or pharmaceutically acceptable salts thereof. | 11-18-2010 |
| 20120070496 | ANTIDEPRESSANT DOSAGE FORM - A dosage form having sustained-release or controlled-release properties for delivering 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol from the dosage form over an extended period of time in a therapeutically responsive dose to produce antidepressant therapy. | 03-22-2012 |
| 20130209562 | METHODS AND DEVICES FOR PROVIDING PROLONGED DRUG THERAPY - Methods and devices for maintaining a desired therapeutic drug effect over a prolonged therapy period are provided. In particular, oral dosage forms that release drug within the gastrointestinal tract at an ascending release rate over an extended time period are provided. The dosage forms may additionally comprise an immediate-release dose of drug. | 08-15-2013 |
| 20130259941 | CONTROLLED RELEASE DOSAGE FORMS - Dosage forms having a core having a surface having means for controlling release(s) on an active agent(s); methods of manufacturing, tools used in manufacturing; and uses of the dosage forms are described. | 10-03-2013 |
| 20130287849 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES - Controlled release formulations and methods for preparing controlled release formulations for delivery of active drug substances are described herein. The formulations described herein may be employed to produce pharmaceutical compositions, such as controlled release dosage forms, adjusted to a specific administration scheme. | 10-31-2013 |
| 20130287850 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES - Controlled release formulations and methods for preparing controlled release formulations for delivery of active drug substances are described herein. The formulations described herein may be employed to produce pharmaceutical compositions, such as controlled release dosage forms, adjusted to a specific administration scheme. | 10-31-2013 |
| 20140030330 | DOSAGE FORMS OF APIXABAN - The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form. | 01-30-2014 |
| 20140302141 | Triple Combination Release Multi-layered Tablet - This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet ( | 10-09-2014 |
| 20140335178 | DOSAGE FORMS OF APIXABAN - The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form. | 11-13-2014 |
| 20160175454 | Tamper-Resistant Pharmaceutical Dosage Forms and Process for Making Same | 06-23-2016 |
